Related Experiment Video
Updated: Jun 26, 2026
09:31
Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Sleep fragmentation correlates with amyloid beta deposition at brain autopsy
Mark A Rudolf1, Yee To Ng2, Andrew P Lieberman1
1Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Summary
Poor sleep quality, especially fragmented sleep, is linked to Alzheimer's disease (AD) brain changes. This connection is strongest in early stages of AD, suggesting sleep disruption may precede significant cognitive decline.
Area of Science:
- Neurology
- Sleep Science
- Gerontology
Background:
- Poor sleep is a recognized symptom and potential risk factor for Alzheimer's disease (AD).
- Investigating the link between longitudinal sleep patterns and AD neuropathology is crucial for understanding disease mechanisms.
Purpose of the Study:
- To determine if objective and subjective longitudinal sleep measures correlate with Alzheimer's disease (AD) pathology.
- To examine the relationship between sleep fragmentation and amyloid deposition in the brain.
Main Methods:
- Utilized data from the Rush Memory and Aging Project (MAP) with 798 participants.
- Annual evaluations included actigraphy for objective sleep, sleep questionnaires for subjective quality, and cognitive assessments.
- Quantitative neuropathologic data was obtained through brain autopsy.
Main Results:
- Objective sleep fragmentation correlated with increased amyloid density in the brain.
- This association was significant in individuals with low AD neuropathologic change or mild cognitive impairment.
- Sleep fragmentation measured closer to death showed a stronger link to amyloid density.
Conclusions:
- Objective sleep fragmentation is histopathologically linked to cerebral amyloid deposition.
- Sleep disruption appears most relevant in the earlier stages of Alzheimer's disease pathogenesis.
- Findings suggest sleep fragmentation may be an early indicator or contributor to AD.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...